PT-141 (10mg)

This research vial contains PT-141 (Bremelanotide), a melanocortin-based peptide studied for its effects on central nervous system signaling and vascular response. Researchers have examined PT-141 in preclinical models for its ability to activate melanocortin receptors related to sexual function and energy regulation.

Blend Composition (Per Vial):
PT-141 – 10mg

Key Characteristics:

• PT-141: Peptide analog studied for CNS and melanocortin pathway activation

• Investigated for effects on neurovascular modulation and behavioral signaling

• Sterile vial designed for consistent reconstitution and peptide preservation

• Stable formulation developed for reproducibility in neurological and vascular studies

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.